Mechanism of Sarpogrelate Action in Improving Cardiac Function in Diabetes

Beneficial Effects of Sarpogrelate Hydrochloride, a 5-ht2aReceptor Antagonist, Supplemented with Pioglitazone on Diabetic Model Mice

(2009) Kenji Iizuka et al.   ENDOCRINE RESEARCH

Plasma serotonin is a predictor for deterioration of urinary albumin excretion in men with type 2 diabetes mellitus

(2009) Michiaki Fukui et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Diabetic Cardiomyopathy: Insights into Pathogenesis, Diagnostic Challenges, and Therapeutic Options

(2008) Ashish Aneja et al.   AMERICAN JOURNAL OF MEDICINE

Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myocardial infarctionThis article is one of a selection of papers published in the special issue Bridging the Gap: Where Progress in Cardiovascular and Neurophysiologic Research Meet.

(2008) Santosh K. Sanganalmath et al.   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy

(2008) Shinya Kobayashi et al.   Clinical and Experimental Nephrology

Reduced Albuminuria with Sarpogrelate Is Accompanied by a Decrease in Monocyte Chemoattractant Protein-1 Levels in Type 2 Diabetes

(2008) S. Ogawa et al.   Clinical Journal of the American Society of Nephrology

Antiplatelet therapy attenuates subcellular remodelling in congestive heart failure

(2008) Santosh K. Sanganalmath et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE